亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials.

特立帕肽 医学 德诺苏马布 唑来膦酸 骨质疏松症 骨矿物 内科学 股骨颈 随机对照试验 泌尿科 外科
作者
Weiyang Wang,L-H Chen,Wendy Ma,Ruxu You
出处
期刊:PubMed 卷期号:27 (17): 8253-8268
标识
DOI:10.26355/eurrev_202309_33586
摘要

This study aims to compare the efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of women with postmenopausal osteoporosis.Randomized controlled trials (RCTs) were searched in Medline, Embase, and Cochrane up to April 2022. Statistical analysis was performed using R 4.1.3 software, and quality evaluation was conducted using Review Manager 5.3.51 RCTs containing 39,095 patients met our selection criteria. The efficacy results indicated that teriparatide was more effective than ibandronic acid in reducing vertebral fractures [relative risk (RR) = 0.536; 95% confidence interval (CI) (0.266, 0.998)]. Denosumab [mean difference (MD) = -4.19; 95% CI (-8.03, -0.355)] and teriparatide [MD = 4.64; 95% CI (1.60, 7.72)] showed better efficacy than ibandronic acid in improving spine bone mineral density (BMD). Denosumab showed better efficacy than teriparatide in improving radius BMD [MD = -4.14; 95% CI (-6.72, -1.54)], hip bone mineral density (BMD) [MD = -2.01; 95% CI (-3.80, -0.162)], and one-third radius BMD [MD = -3.63; 95% CI (-7.04, -0.151)]. Denosumab was associated with the greatest benefit in increasing radius BMD [the surface under the cumulative ranking curve area (SUCRA) = 0.999], hip BMD [surface under the cumulative ranking curve area (SUCRA) = 0.979], femoral neck BMD (SUCRA = 0.971), one-third radius BMD (SUCRA = 0.994) and preventing vertebral fractures (SUCRA = 0.806). Teriparatide was associated with the greatest benefit in preventing non-vertebral fractures (SUCRA = 0.927) and improving spine BMD (SUCRA = 0.899). The safety results indicated that teriparatide was safer than zoledronic acid regarding the risk of adverse events [RR = 0.958; 95% CI (0.919, 0.988)]. Teriparatide was associated with the greatest benefit in preventing adverse events (SUCRA = 0.908) and serious adverse events (SUCRA = 0.813).Our current results suggested that when considering both safety and efficacy, denosumab or teriparatide might be a better choice for women with postmenopausal osteoporosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fukase发布了新的文献求助10
3秒前
jiangjiang完成签到 ,获得积分10
11秒前
18秒前
科研通AI2S应助科研通管家采纳,获得10
20秒前
tsttst完成签到,获得积分10
37秒前
42秒前
51秒前
56秒前
Qiuyajing完成签到,获得积分10
1分钟前
1分钟前
星辰大海应助兴奋的嘉懿采纳,获得10
1分钟前
祖之微笑发布了新的文献求助10
1分钟前
兴奋的嘉懿完成签到,获得积分20
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
葱饼完成签到 ,获得积分10
2分钟前
香蕉觅云应助sunshihaoya采纳,获得10
2分钟前
2分钟前
2分钟前
2分钟前
量子星尘发布了新的文献求助10
3分钟前
机灵自中发布了新的文献求助10
3分钟前
机灵自中完成签到,获得积分10
3分钟前
执着的草丛完成签到,获得积分10
3分钟前
3分钟前
Anna完成签到 ,获得积分10
3分钟前
4分钟前
绝世冰淇淋完成签到 ,获得积分10
4分钟前
科研通AI5应助科研通管家采纳,获得50
4分钟前
breeze完成签到,获得积分10
4分钟前
量子星尘发布了新的文献求助10
4分钟前
4分钟前
顺心蜜粉给远航的求助进行了留言
4分钟前
silence发布了新的文献求助10
4分钟前
zhanglq发布了新的文献求助10
4分钟前
silence完成签到,获得积分10
4分钟前
CipherSage应助zhaoaotao采纳,获得10
4分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976649
求助须知:如何正确求助?哪些是违规求助? 3520756
关于积分的说明 11204743
捐赠科研通 3257502
什么是DOI,文献DOI怎么找? 1798733
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806629